Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated balance sheets

v3.25.0.1
Consolidated balance sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 63,869 $ 71,732
Restricted deposits 10,572 10,020
Accounts receivable, net 50,975 47,869
Deferred contract costs 11,373 11,165
Prepaid expenses and other current assets 4,567 5,599
Total current assets 141,356 146,385
Property and equipment, net 25,921 28,630
Deferred contract costs, non-current 9,895 9,845
Operating lease right-of-use assets 34,393 36,007
Intangible assets, net 5,577 4,785
Goodwill 25,269 12,867
Other non-current assets 500 494
Total assets 242,911 239,013
Current liabilities:    
Borrowings under Credit Facility 0 25,000
Accounts payable 12,403 8,422
Payroll and benefit related liabilities 20,304 20,437
Deferred revenue 108,232 99,968
Other payables and accrued expenses 29,330 23,263
Operating lease liabilities 6,923 7,095
Total current liabilities 177,192 184,185
Deferred revenue, non-current 1,172 878
Operating lease liabilities, non-current 32,809 35,329
Other long-term liabilities 4,230 3,074
Total liabilities 215,403 223,466
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary Shares, NIS 0.01 par value 500,000,000 shares authorized as of December 31, 2023 and 2024; 78,653,046 and 82,620,679 shares issued as of December 31, 2023 and 2024, respectively; 78,650,878 and 82,618,511 shares outstanding as of December 31, 2023 and 2024, respectively; 2,168 treasury shares as of December 31, 2023 and 2024; 227 216
Additional paid-in capital 391,449 367,558
Accumulated other comprehensive income 388 872
Accumulated deficit (364,556) (353,099)
Total shareholders' equity 27,508 15,547
Total liabilities and shareholders' equity $ 242,911 $ 239,013